IG therapy
Fundamentals of Subcutaneous Immunoglobulin Therapy
Subcutaneous Ig and facilitated SCIG products enable patients to self-administer Ig therapy at home, promoting ...
AUGUST 7, 2025
Immunologic and Anaphylactoid Reactions in Ig Therapy
Immunoglobulin therapy carries the risk for infusion-related reactions that range from mild to life-threatening.
JUNE 13, 2025
Aseptic Meningitis Syndrome With Immunoglobulin Therapy
Aseptic meningitis syndrome is a recognized but relatively rare adverse event associated with intravenous ...
MAY 23, 2025
Forging Better Immune Globulin Outcomes
Two new studies presented at the IgNS 2024 National Conference offer insight into treatment options for immune ...
APRIL 28, 2025
Team Collaboration Crucial in Delivering Safe, Effective Ig Therapy
Las Vegas—The current edition of the Immunoglobulin National Society's (IgNS) “Immunoglobulin ...
OCTOBER 22, 2021
Despite Predictions, Still No Sign of IG Supply Shortage
The anticipated immunoglobulin (IG) therapy shortage resulting from the COVID-19 pandemic has still not emerged.
SEPTEMBER 27, 2021
